Wave Life Sciences (WVE) EBIT Margin (2015 - 2026)
Wave Life Sciences posted quarterly EBIT Margin of 81.83% for Q1 2026, up 46099.0% year-on-year from N/an in Q1 2025, and up 86.51% on a QoQ basis from 606.49% in Q2 2025.
Wave Life Sciences (WVE) has 12 years of EBIT Margin data on file, last reported at 81.83% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 46099.0% year-over-year to 81.83%; the trailing twelve-month figure through Mar 2026 stood at 259.69% (down 8122.0% YoY), and the FY2025 full-year result was 504.09%, down 40215.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 81.83%, up from 606.49% in the prior quarter.
- Across five years, EBIT Margin topped out at 9.03% in Q3 2023 and bottomed at 13648.77% in Q3 2022.
- The 5-year median for EBIT Margin is 274.83% (2024), against an average of 2512.67%.
- The widest annual swing landed in 2022, when EBIT Margin tumbled 1362789 bps; it then surged 1365780 bps in 2023.
- A 5-year view of EBIT Margin shows it stood at 3515.98% in 2022, then surged by 98 bps to 64.3% in 2023, then sank by 176 bps to 177.72% in 2024, then tumbled by 241 bps to 606.49% in 2025, then jumped by 87 bps to 81.83% in 2026.
- The last three EBIT Margin figures came in at 81.83% (Q1 2026), 606.49% (Q2 2025), and 542.82% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | -81.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81.83% |
| Jun 30, 2025 | -606.49% |
| Mar 31, 2025 | -542.82% |
| Jun 30, 2024 | -177.72% |
| Mar 31, 2024 | -274.83% |
| Dec 31, 2023 | -64.30% |
| Sep 30, 2023 | 9.03% |
| Jun 30, 2023 | -106.18% |
| Mar 31, 2023 | -234.24% |
| Dec 31, 2022 | -3,515.98% |
| Sep 30, 2022 | -13,648.77% |
| Jun 30, 2022 | -11,243.73% |
| Mar 31, 2022 | -2,176.80% |
| Dec 31, 2021 | -2,045.89% |
| Sep 30, 2021 | -20.89% |
| Jun 30, 2021 | -1,434.73% |
| Dec 31, 2020 | -321.15% |
| Sep 30, 2020 | -997.54% |
| Jun 30, 2020 | -1,277.04% |
| Mar 31, 2020 | -1,201.47% |
| Dec 31, 2019 | -2,522.21% |
| Sep 30, 2019 | -1,849.74% |
| Jun 30, 2019 | -598.02% |
| Mar 31, 2019 | -1,585.86% |
| Dec 31, 2018 | -1,352.02% |
| Sep 30, 2018 | -850.92% |
| Jun 30, 2018 | -749.60% |
| Mar 31, 2018 | -2,515.82% |
| Dec 31, 2017 | -2,837.70% |
| Sep 30, 2017 | -2,004.03% |
| Jun 30, 2017 | -2,249.13% |
| Mar 31, 2017 | -5,275.98% |
| Dec 31, 2016 | -2,737.28% |
| Sep 30, 2016 | -4,396.17% |
| Jun 30, 2016 | -2,790.89% |
| Jun 30, 2015 | -2,880.16% |
| Mar 31, 2015 | -13,326.92% |